During the past decade, Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o." #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o." #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o." are "Systemic Lupus Erythematosus" (2 trials), "Arthritis, Psoriatic" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Moderate to Severe Rheumatoid Arthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o." are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials) and "EU-Humira" (1 trials). Other intervention names were less common.

The vast majority of trials in "Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".